Triplet Therapeutics
Latest round
- Series A
Last raised
- Dec 2019
Total raised
- $39M
Investors
- 6
About Triplet Therapeutics
Triplet Therapeutics, Inc.Triplet Therapeutics, Inc. was founded in 2019 and is headquartered in Cambridge, US. The company is dedicated to pioneering treatments for triplet repeat disorders, utilizing advanced biotechnology. The founder, Nessan Bermingham, has a history of leadership in biotech ventures. In October 2022, Triplet Therapeutics, Inc.Triplet Therapeutics, Inc. focuses on developing innovative therapies specifically designed to address triplet repeat disorders, which are genetic conditions caused by the expansion of certain DNA sequences.Triplet Therapeutics, Inc. had anticipated launching new therapeutic candidates targeting triplet repeat disorders. However, as the company has since discontinued its operations, the future growth plans and market expansion strategies are no longer applicable.
Who invested in Triplet Therapeutics
6 investors across 2 rounds
See all investors in Triplet Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Triplet Therapeutics
Who invested in Triplet Therapeutics?
Triplet Therapeutics has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Triplet Therapeutics raised?
Triplet Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Triplet Therapeutics last raise money?
Triplet Therapeutics's most recent round on record is a Series A, in Dec 2019.
What does Triplet Therapeutics do?
Triplet Therapeutics is a biotechnology company.
Where is Triplet Therapeutics headquartered?
Triplet Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Triplet Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Triplet Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Triplet Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.